c

Renal Diseases Market Reports Empesis on Targeting Immune and Hormone Signaling Dominating the Pipeline for Chronic Kidney Disease

The Frontier Pharma: Renal Diseases High Degree of Innovation and Diversity with Products Targeting Immune and Hormone Signaling Dominating the Pipeline for Chronic Kidney Disease assesses first-in-class innovation in the renal diseases pipeline, highlighting key trends and emerging treatment classes.

Pune, India - March 14, 2018 /MarketersMedia/ —

The renal diseases therapy area encompasses a range of diseases of the kidney, such as chronic kidney disease (CKD), acute kidney injury, diabetic nephropathy and focal segmental glomerulosclerosis. Renal diseases are becoming increasingly common due to the increased prevalence of hypertension and diabetes, two major causes of CKD. For most forms of renal diseases, early detection and management may slow down or prevent progression to renal failure and associated complications. However, many renal diseases are typically asymptomatic until they have progressed to end-stage renal disease (ESRD), which requires renal replacement therapies such as hemodialysis and renal transplantation, and is associated with substantial morbidity and mortality.

Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-renal-diseases-high-degree-of-innovation-and-diversity-with-products-targeting-immune-and-hormone-signaling-dominating-the-pipeline-for-chronic-kidney-disease

The first-in-class programs identified show considerable diversity, and the relatively high degree of innovation in the renal diseases therapy area makes for a promising development pipeline. It is clear that recent activity in this area has increased, partly owing to the growing recognition of the unmet medical need. Further investment in innovation would benefit the therapy area greatly, and likely prove a worthwhile investment, particularly for highly prevalent diseases such as CKD and diabetic nephropathy, for which there are a lack of effective pharmacotherapeutic options.

Get this report at: https://www.themarketreports.com/report/buy-now/935551

Scope
• With 365 products in active development, the pipeline is modestly sized. Does current pipeline innovation hold the potential to affect the future renal diseases market?
• There are 100 first-in-class products in the renal diseases pipeline. Which of these hold the greatest potential to improve future disease treatment with regard to their molecular target?
• The majority of first-in-class products were in development for indications involving inflammation. Which first-in-class targets are most promising, and how does the ratio of first-in-class targets to first-in-class products differ by stage of development and molecular target class?
• A significant number of first-in-class products have been identified with no prior involvement in deals. How do deal frequency and value compare between target families and molecule types, and which first-in-class programs have not yet been involved in a licensing or co-development deal?

Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/935551

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/renal-diseases-market-reports-empesis-on-targeting-immune-and-hormone-signaling-dominating-the-pipeline-for-chronic-kidney-disease/314328

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-renal-diseases-high-degree-of-innovation-and-diversity-with-products-targeting-immune-and-hormone-signaling-dominating-the-pipeline-for-chronic-kidney-disease%20%20

Source: MarketersMedia

Release ID: 314328

Latest News

Koepka's golf legacy secured after 2nd straight Open win

Jun 18, 2018

SOUTHAMPTON, N.Y. — For a guy who has won all of three PGA Tour events, Brooks Koepka has a golf legacy that already is secure. That's how it should be for winning back-to-back U.S. Opens. Koepka became the first man to turn that impressive trick in nearly three decades by handling a Shinnecock Hills course that varied from beastly to benign. His one-stroke victory Sunday over Tommy Fleetwood even topped Koepka's first major victory a year ago at Erin Hills. "I don't want to say I didn't think I could do it, but I knew that it was going to...

Strange: Koepka has what it takes to win 3 in a row

Jun 18, 2018

SOUTHAMPTON, N.Y. — Curtis Strange stood by the 18th green at Shinnecock Hills, working for the TV broadcast and ready to welcome Brooks Koepka into the small fraternity of back-to-back U.S. Open winners. "I'm happy for him. I hope it means as much to him," said Strange, who won in 1988 and '89 and was the last to win two in a row before Koepka matched him Sunday. "Now he's going to learn things about Willie Anderson that I learned about that I never thought I would. A year after shooting 16 under to win at Erin Hills by four...

Dustin Johnson's US Open hopes fade on back 9

Jun 18, 2018

SOUTHAMPTON, N.Y. — Dustin Johnson had a four-stroke lead after 36 holes and was still in striking distance heading onto the back nine in the final round of the U.S. Open. Instead of making a move, he lost ground. The 2016 champion three-putted three times on the back nine at Shinnecock Hills, shooting an even-par 70 on Sunday to finish third, two strokes back, as workout buddy and final-round partner Brooks Koepka claimed his second U.S. Open title in a row. "When we're all done, he's going to win another one," Koepka said. "I mean, we all know that. ......

Tough course or easy, Brooks Koepka repeats as US Open champ

Jun 18, 2018

SOUTHAMPTON, N.Y. — One was about power. The other was about patience. Brooks Koepka has a game for the U.S. Open no matter the course, no matter the test, no matter the circumstances. He never lost hope when he began his title defense with a 75 and was 7-over par midway through the second round. He didn't lose his mind in the most punishing third round of a U.S. Open in nearly two decades. And with a cool head and a hot putter, he didn't give anyone a chance down the stretch Sunday at Shinnecock Hills. Koepka pulled away from...

A glance at the final round of the US Open

Jun 18, 2018

A glance at the final round of the U.S. Open at Shinnecock Hills in Southampton, New York: Winner: Brooks Koepka, who shot a final-round 68 to finish at 1-over 281. Just behind: Tommy Fleetwood, who tied a U.S. Open record with a final-round 63. He was a shot back at 282. Dustin Johnson finished another shot back, followed by Masters champion Patrick Reed at 4-over-par. Back-to-back: It was the second straight U.S. Open title for Koepka, the first player do to it since Curtis Strange in 1989. Notable: Koepka's 75 on Thursday was the highest first round of a U.S....

Search
Broaden News

5 Stars Discovery brings you to the stories from people around the world sharing on the finest luxury resorts, high-end city hotels, and exclusive hideaway to make sure you’ll get the premium experience.

Contact us: sales@starsdiscovery.com